Chien Yew Kow1, James Caldwell2, Frances Mchugh1, Hamish Sillars3, Arnold Bok4. 1. Neurosurgery Department, Auckland City Hospital, Auckland, New Zealand. 2. Radiology Department, Auckland City Hospital, Auckland, New Zealand. 3. Otorhinolaryngology Department, Auckland City Hospital, Auckland, New Zealand. 4. Neurosurgery Department, Auckland City Hospital, Auckland, New Zealand. Electronic address: AriB@adhb.govt.nz.
Abstract
INTRODUCTION: Dural venous sinus thrombosis is an uncommon, but significant sequela that may occur after resection of a cerebellopontine angle lesion. The natural history and management of this pathology has not been sufficiently studied. METHODS: All operative cases for cerebellopontine angle lesions performed in our local institution dating from 1 January 2005 to 30 June 2018 were retrospectively reviewed to identify patients who developed new post-operative dural venous sinus thrombosis. Patients who developed a significantly narrowed sinus without intrinsic thrombus were also identified. Progression of sinus thrombosis through time was followed, with comparisons made between complications amongst patients with and without a compromised sinus. RESULTS: Of the 126 patients, 20 were found to have new sinus thrombosis, with another 16 developing a critically narrowed sinus without intrinsic thrombus. These cases are significantly associated with translabyrinthine resection of acoustic schwannoma. 4 patients amongst the thrombosed group were commenced on additional therapeutic anticoagulation or antiplatelets, whilst the rest were observed. Based on available follow up imaging, 10/17 patients had significantly improved sinus thrombosis on serial imaging, including 8/14 amongst those not given additional anticoagulation. Patients with a compromised sinus demonstrated a higher rate of cerebrospinal fluid leak requiring blindsac procedures. When involving a dominant sinus, there is also an association of an increased requirement for permanent CSF diversion. CONCLUSION: Therapeutic anticoagulation should be considered for symptomatic post-operative dural venous sinus thrombosis or if it involves a dominant sinus. Further prospective studies are warranted to better elucidate the risk-benefit justification of treatment for postoperative sinus thrombosis.
INTRODUCTION:Dural venous sinus thrombosis is an uncommon, but significant sequela that may occur after resection of a cerebellopontine angle lesion. The natural history and management of this pathology has not been sufficiently studied. METHODS: All operative cases for cerebellopontine angle lesions performed in our local institution dating from 1 January 2005 to 30 June 2018 were retrospectively reviewed to identify patients who developed new post-operative dural venous sinus thrombosis. Patients who developed a significantly narrowed sinus without intrinsic thrombus were also identified. Progression of sinus thrombosis through time was followed, with comparisons made between complications amongst patients with and without a compromised sinus. RESULTS: Of the 126 patients, 20 were found to have new sinus thrombosis, with another 16 developing a critically narrowed sinus without intrinsic thrombus. These cases are significantly associated with translabyrinthine resection of acoustic schwannoma. 4 patients amongst the thrombosed group were commenced on additional therapeutic anticoagulation or antiplatelets, whilst the rest were observed. Based on available follow up imaging, 10/17 patients had significantly improved sinus thrombosis on serial imaging, including 8/14 amongst those not given additional anticoagulation. Patients with a compromised sinus demonstrated a higher rate of cerebrospinal fluid leak requiring blindsac procedures. When involving a dominant sinus, there is also an association of an increased requirement for permanent CSF diversion. CONCLUSION: Therapeutic anticoagulation should be considered for symptomatic post-operative dural venous sinus thrombosis or if it involves a dominant sinus. Further prospective studies are warranted to better elucidate the risk-benefit justification of treatment for postoperative sinus thrombosis.
Authors: Christina Gerges; Patrick Malloy; Nicholas Rabah; Dana Defta; Yifei Duan; Christina H Wright; Marte van Keulen; James Wright; Sarah Mowry; Cliff A Megerian; Nicholas Bambakidis Journal: J Neurol Surg B Skull Base Date: 2021-02-04
Authors: Nida Fatima; Zachary R Barnard; Anne K Maxwell; Tommy J Muelleman; William H Slattery; Gautam U Mehta; Willis Wagner; Gregory P Lekovic Journal: Front Surg Date: 2022-04-28
Authors: Kamil Krystkiewicz; Dawid Wrona; Marcin Tosik; Marcin Birski; Łukasz Szylberg; Anna Morawska; Jacek Furtak; Cezary Wałęsa; Konrad Stopa; Marek Harat Journal: Neurosurg Rev Date: 2022-01-21 Impact factor: 3.042